ImmunoGen, Inc. Quarterly Income Tax Expense (Benefit) in USD from Q4 2011 to Q3 2023
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
ImmunoGen, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q4 2011 to Q3 2023.
- ImmunoGen, Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2023 was -$1.17M.
- ImmunoGen, Inc. annual Income Tax Expense (Benefit) for 2022 was $1.22M.
- ImmunoGen, Inc. annual Income Tax Expense (Benefit) for 2021 was $0.000.
- ImmunoGen, Inc. annual Income Tax Expense (Benefit) for 2020 was $0.000.
Income Tax Expense (Benefit), Quarterly (USD)